Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Alicia I Hidron1,2, Russell Kempker2, Abeer Moanna1,2, David Rimland1,2
1Atlanta Veterans Affairs Medical Center, Decatur, GA, USA; 2Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA
Abstract: Concordant with the emergence of methicillin-resistant Staphylococcus aureus (MRSA) in the community setting, colonization and infections with this pathogen have become a prevalent problem among the human immunodeficiency virus (HIV)-positive population. A variety of different host- and, possibly, pathogen-related factors may play a role in explaining the increased prevalence and incidence observed. In this article, we review pathophysiology, epidemiology, clinical manifestations, and treatment of MRSA in the HIV-infected population.
Keywords: MRSA, Staphylococcus aureus, HIV, resistance
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.